Content Preview
Newsday 7 day/Optimum Online® subscribers click here for full access
Not a Newsday or Optimum Online® subscriber? Click here
AstraZeneca drug wins partial US approval
Quick ReadAstraZeneca receives partial approval for depression drug from US regulators
LONDON (AP) — Pharmaceutical company AstraZeneca PLC said Friday it has won U.S. approval for use of its schizophrenia drug Seroquel XR as an add-on treament for major depressive disorder.
But the London-based company said that the U.S. Food and Drug Administration has asked for more information before allowing the drug's use as a single agent to treat major depressive disorder, or MDD.
Seroquel...
Newsday & ExploreLI are now available at no charge to Newsday 7-day and Optimum Online® subscribers. To continue reading, please log in or register now.
